Saturday 17 October 2026 Export NBIX’s income statement to Excel — free account

Neurocrine Biosciences, Inc.

NBIX Healthcare Drug Manufacturers Specialty & Generic

Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024. In the quarter to June 2026, revenue grew 39.5%, EPS grew 31.2% and free cash flow grew 43.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five.

135.71 1.24 −0.91%

Follow NBIX

Alert me

Market cap: $13.9B
P/E: 19.2×
Fwd P/E: 30.5×
Dividend yield: —
F-score: 7/9
Altman Z: 7.80
Beneish M: −2.64
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	14.96%	16.38%	22.50%	22.09%
Piotroski F-Score Full definition →		5	7	7	6
ROA Full definition →		10.97%	11.46%	15.56%	15.26%
ROIC Full definition →		18.21%	21.83%	23.58%	15.04%
Return on Tangible Assets Full definition →		26.46%	25.61%	39.44%	82.66%
Average Days of Receivables Full definition →		99.05	87.64	90.37	95.96
Free Cash Flow per Share Full definition →		5.97	7.52	8.27	8.62
Free Cash Flow Full definition →		593.10	748.70	831.30	870.40
Capital Expenditures Full definition →		(43.70)	(34.00)	(32.40)	(27.70)
Other line items
Cash ROIC Full definition →		14.40%	15.82%	17.60%	21.32%
Accounts Receivable Turnover Full definition →		4.44	4.91	4.83	4.55
Accounts Payable Turnover Full definition →		0.09	0.09	0.09	0.11
Inventory Turnover Full definition →		0.74	0.82	0.92	0.86
Average Days of Payables Full definition →		4,982.93	4,723.98	4,976.10	4,238.93
Days of Inventory on Hand Full definition →		590.99	483.40	415.21	546.45
Tax Rate Full definition →		(0.32)	(0.32)	(0.29)	(0.25)
Research and Development Expense of Revenue Full definition →		35.15%	35.51%	33.80%	33.52%
Selling, General and Administrative Expense of Revenue Full definition →		42.58%	40.42%	38.62%	40.06%
Share Based Compensation of Revenue Full definition →		8.41%	7.62%	7.17%	6.95%
Interest Coverage Full definition →		—	—	—	92.42
Operating CF/Net income Full definition →		1.49	1.64	1.29	1.27
Depreciation/Fixed assets Full definition →		0.04	0.19	0.19	0.42
Capex/Depreciation Full definition →		(12.49)	(1.95)	(1.89)	(0.74)
Revenue per Share Full definition →		26.99	28.75	30.87	33.41
Operating CF per Share Full definition →		6.41	7.87	8.59	8.89
Capex per Share Full definition →		(0.44)	(0.34)	(0.32)	(0.27)
Capex to Sales Full definition →		0.02	0.01	0.01	0.01

Show all line items

Columns are period end dates

Stockrow Weekly